Daniel Sejerøe Hausenkamph

Daniel Sejer Pedersen is an accomplished chemical development specialist with extensive experience in the pharmaceutical industry and academia. Currently at Novo Nordisk since June 2017, Daniel holds the title of Chemical Development Specialist, where responsibilities include coordinating outsourced R&D projects for clinical phases II and III, focusing on small-molecule, peptide, and peptidomimetic chemistry. Prior to this role, Daniel served as a Senior Development Scientist at Novo Nordisk and held multiple academic positions at the University of Copenhagen, including Associate Professor and Visiting Associate Professor. Daniel's research expertise encompasses medicinal chemistry related to G protein-coupled receptors and antibiotic development. Educational qualifications include a PhD in Synthetic Organic Chemistry from the University of Cambridge and a Cand. scient. in Organic Chemistry from the University of Copenhagen.